These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9875340)

  • 1. Up- and down-expression of the dopamine transporter by plasmid DNA transfer in the rat brain.
    Martres MP; Demeneix B; Hanoun N; Hamon M; Giros B
    Eur J Neurosci; 1998 Dec; 10(12):3607-16. PubMed ID: 9875340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homeostatic regulation of serotonergic function by the serotonin transporter as revealed by nonviral gene transfer.
    Fabre V; Boutrel B; Hanoun N; Lanfumey L; Fattaccini CM; Demeneix B; Adrien J; Hamon M; Martres MP
    J Neurosci; 2000 Jul; 20(13):5065-75. PubMed ID: 10864964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
    Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
    J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum.
    Kanthasamy A; Sprague JE; Shotwell JR; Nichols DE
    Neuroscience; 2002; 114(4):917-24. PubMed ID: 12379247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo in the rat.
    Régo JC; Syringas M; Leblond B; Costentin J; Bonnet JJ
    Br J Pharmacol; 1999 Sep; 128(1):51-60. PubMed ID: 10498834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo electrochemical studies of dopamine clearance in the rat substantia nigra: effects of locally applied uptake inhibitors and unilateral 6-hydroxydopamine lesions.
    Hoffman AF; Gerhardt GA
    J Neurochem; 1998 Jan; 70(1):179-89. PubMed ID: 9422361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity.
    Morón JA; Zakharova I; Ferrer JV; Merrill GA; Hope B; Lafer EM; Lin ZC; Wang JB; Javitch JA; Galli A; Shippenberg TS
    J Neurosci; 2003 Sep; 23(24):8480-8. PubMed ID: 13679416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased plasma membrane expression of striatal dopamine transporter in aging.
    Salvatore MF; Apparsundaram S; Gerhardt GA
    Neurobiol Aging; 2003 Dec; 24(8):1147-54. PubMed ID: 14643386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system.
    Lorenc-Koci E; Antkiewicz-Michaluk L; Wardas J; Zapała M; Wierońska J
    Brain Res; 2004 May; 1009(1-2):67-81. PubMed ID: 15120584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices.
    Hoffman AF; Lupica CR; Gerhardt GA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):487-96. PubMed ID: 9808671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.
    Fumagalli F; Gainetdinov RR; Valenzano KJ; Caron MG
    J Neurosci; 1998 Jul; 18(13):4861-9. PubMed ID: 9634552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration.
    Letchworth SR; Sexton T; Childers SR; Vrana KE; Vaughan RA; Davies HM; Porrino LJ
    J Neurochem; 1999 Nov; 73(5):1982-9. PubMed ID: 10537056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
    Van Kampen JM; McGeer EG; Stoessl AJ
    Synapse; 2000 Sep; 37(3):171-8. PubMed ID: 10881039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of striatal dopaminergic function induced by glioma development: a microdialysis and immunohistological study in the rat striatum.
    Lonjon M; Quentien MH; Risso JJ; Michiels JF; Carre E; Rostain JC; Darbin O
    Neurosci Lett; 2004 Jan; 354(2):131-4. PubMed ID: 14698456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and regulation of the human dopamine transporter in a neuronal cell line.
    Zhang L; Elmer LW; Little KY
    Brain Res Mol Brain Res; 1998 Aug; 59(1):66-73. PubMed ID: 9729282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat.
    Barc S; Page G; Barrier L; Garreau L; Guilloteau D; Fauconneau B; Chalon S
    J Neurochem; 2002 Feb; 80(3):365-74. PubMed ID: 11905985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide derived from insulin with regulatory activity of dopamine transporter.
    Liu Z; Wang Y; Zhao W; Ding J; Mei Z; Guo L; Cui D; Fei J
    Neuropharmacology; 2001 Sep; 41(4):464-71. PubMed ID: 11543766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex.
    Zhu J; Apparsundaram S; Bardo MT; Dwoskin LP
    J Neurochem; 2005 Jun; 93(6):1434-43. PubMed ID: 15935059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.